Jpmorgan Chase & Co »

Kiora Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Kiora Pharmaceuticals shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Kiora Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiora Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiora Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $4 1 4.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Kiora Pharmaceuticals

AIGH Capital Management
Nantahala Capital Management
Alyeska Investment Group
Geode Capital Management
BlackRock
Goss Wealth Management
Bank of America Corporation
Us Bancorp
Activest Wealth Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Kiora Pharmaceuticals